# Editorial: Nanomedicine targeting central nervous system

**Authors:** Tara Chand Yadav, Barkha J. Yadav-Samudrala, Sylvia Fitting

PMC · DOI: 10.3389/fmed.2026.1755137 · 2026-02-03

## Full-text entities

- **Genes:** CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}
- **Diseases:** Parkinson's disease (MESH:D010300), gliomas (MESH:D005910), Neurodegenerative Disease (MESH:D019636), Huntington's (MESH:D006816), Alzheimer's (MESH:D000544), neuropsychiatric conditions (MESH:D001523), brain disorder (MESH:D001927), Parkinson's symptoms (MESH:D010302), brain cancer (MESH:D001932), nervous system disorders (MESH:D009422), multiple sclerosis (MESH:D009103), CNS (MESH:D002494)
- **Chemicals:** gold (MESH:D006046), carbon nanotubes (MESH:D037742), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12909200